Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

VR eye workouts could help people with eye nerve damage move their eyes better

NCT ID NCT06417216

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tests whether doing eye exercises in virtual reality can help people with certain eye nerve palsies move their eyes more. The VR scene moves with the person's head while they do visual tasks. The goal is to see if this improves eye movement range. The study involves 40 participants with abducens palsy or internuclear ophthalmoplegia.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
head-cancelled virtual reality
What this could lead to
If it works, this could offer a new, non-invasive way to improve eye movement in people with certain nerve palsies.
What could go wrong
This is a small, early-stage study with only 40 participants. It may not show significant improvement, and results may not apply to all types of eye nerve palsy.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 40 people

The number the study aims to enrol. It can still change while the study runs.

Started

Sep 2024

Expected to finish

Jun 2028

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

OCNP Group Inclusion Criteria: * Presence of OCNP in one eye with 50% range-of-motion limitation or worse * Able to provide informed consent and will be able to fluently read and understand spoken English OCNP Group Exclusion Criteria: * Presence of bilateral OCNP * Range of motion better than 50% * Visual acuity worse than 20/100 in either eye * Greater than 4-line difference in visual acuity between the eyes, * Structural anomalies or sensory sensitivities (e.g. visual motion sensitivity) that would prevent them from wearing or tolerating a VR headset Participants will be excluded if they are unable to participate if inclusion criteria are not met. Normal Group Inclusion Criteria: * Absence of OCNP or other neurological or neuro-ophthalmic diseases * No strabismus * Have normal or near-normal vision with glasses or contact lenses. * Be able to provide informed consent and will be able to fluently read and understand spoken English Normal Group Exclusion Criteria: * Visual acuity worse than 20/100 in either eye * Greater than 4-line difference in visual acuity between the eyes * Structural anomalies or sensory sensitivities (e.g. visual motion sensitivity) that would prevent them from wearing or tolerating a VR headset * Known inability to tolerate visual testing of at least 20 minutes continuously.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Internuclear ophthalmoplegia are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

Abducens Nerve Diseases abducens nerve palsy internuclear ophthalmoplegia Ocular Motility Disorders

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    2 sites. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Brooks Rehabilitation Hospital

    RECRUITING

    Jacksonville, Florida, 32216, United States

  • Vision Source of Worcester

    RECRUITING

    Worcester, Massachusetts, 01610, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.